Abstract
The alkyne functional group can be a valuable handle for organic synthesis since the alkyne can function both as a nucleophile or as an electrophile when activated with an appropriate metal catalyst. Herein, we exploit this dual nature of the alkyne moiety for the concise total synthesis of the natural product soraphen A.
Keywords: alkynes, asymmetric synthesis, macrolactones, natural products, total synthesis
Soraphen A (1, Scheme 1) is a complex polyketide natural product discovered in 1986 when it was isolated from the soil bacterium Sorangium cellulosum by Höfle and coworkers.[1] Importantly, 1 is a potent antifungal agent possessing activity against a broad spectrum of fungi.[2] Furthermore, the antifungal activity of 1 results from a unique mode of action, whereby selective inhibition of the acetyl-CoA carboxylase (ACC) enzyme of the fungus results in cell death by disruption of lipid synthesis in the cell.[3] As a result, 1 has the potential for application in the treatment of obesity, diabetes,[4] and cancer.[5] Structurally, 1 is comprised of an 18-membered macrolactone, including 10 stereocenters and a highly substituted pyranose ring system. These features make 1 a challenging target for total synthesis. To date, only one completed total synthesis of 1 has been reported by Giese and coworkers.[6] In addition, several groups have reported their efforts towards the synthesis of 1.[7] Herein we report our asymmetric total synthesis of 1 that relies on the versatility of the alkyne functional group to provide a concise route to 1.
Scheme 1.

Retrosynthetic analysis. PMB = para-methoxybenzyl, TBS = tert-butyldimethylsilyl, BDMS = benzyldimethylsilyl, Bn = benzyl.
Alkynes are versatile functional groups because they can be used both as nucleophiles by deprotonation of a terminal alkyne and as electrophiles[8] by activation of the alkyne with a transition metal. Our retrosynthetic plan (Scheme 1) was devised around this concept of using the dual nature of the alkyne moiety to provide a concise synthesis of the target. Accordingly, the C10–C11 bond could arise from a Felkin-selective acetylide addition of alkyne 3 to aldehyde 2. Subsequent treatment of the resultant internal alkyne in a hydrosilylation/protodesilylation[9] sequence should conveniently allow for reduction of the alkyne to the requisite C9–C10 trans olefin present in 1. The completion of 1 was then envisioned to arise from a late stage macrolactonization.[10]
The hemiketal portion of 1 was envisioned to arise from treatment of ketone 3 (R2 = H) with acid. The α-alkoxyketone 3 was then proposed to arise from oxidation of epoxysilane 4. We have previously demonstrated the utility of epoxysilanes as masked α-hydroxyketones, wherein Tamao-Fleming oxidation of the epoxysilane conveniently unmasks this group.[11] Furthermore, these epoxysilanes are readily prepared from an alkyne functional group by hydrosilylation followed by epoxidation. Thus, an alkyne serves as a convenient synthon for an α-hydroxyketone facilitating C–C bond formation and minimizing the use of protecting groups. Installation of the requisite stereochemistry at C6 and C7 in 4 could arise from a substrate controlled diastereoselective aldol between ketone 6 and aldehyde 7 while forming the C6–C7 bond. Finally, aldehyde 2 was envisioned to arise from alkyne 5 by a catalyst controlled acetylide addition of the alkyne to benzaldehyde using the dinuclear zinc catalyst system[12] developed in our laboratory. Furthermore, alkyne 5 in turn derives from an epoxide opening with a terminal alkyne as well. Both terminal alkynes have their origin in 1-propyne where it serves as a lynchpin. After utilizing the terminal alkyne of 1-propyne as a nucleophile, zipping[13] it recreates a new terminal alkyne to repeat its functioning as a new nucleophile. This reactivity profile provides two strategies for controlling absolute stereochemistry: use of the chiral pool and catalyst controlled asymmetric induction.
Synthesis of the aldehyde fragment began with the preparation of alkyne 5 in 3 steps from (S)-glycidol (Scheme 2). Epoxide opening with the Li-acetylide of propyne, followed by isomerization of the internal alkyne to the terminal position using potassium 3-aminopropylamide,[13] and TBS protection of the diol gave 5. Coupling of 5 and benzaldehyde using 10 mol% (S,S)-8 as ligand furnished the desired propargylic alcohol 9 in excellent yield and diastereoselectivity. Exhaustive reduction of the alkyne to the alkane using Adams’ catalyst[14] proceeded in excellent yield with minimal reduction of the benzylic alcohol as is often observed when using Pd/C as catalyst.[15] The benzylic secondary alcohol was then protected as a PMB ether followed by selective deprotection of the primary TBS ether using HF · pyr. Finally, Moffatt-Swern oxidation provided aldehyde 10 in excellent yield.
Scheme 2.

Synthesis of the aldehyde fragment. a) propyne, n-BuLi, THF/DMPU (10/1), −78 °C to RT, 20 h, 68%; b) 1,3-diaminopropane, Li, KOtBu, 66%; c) TBSCl, imidazole, DMF, 0 °C to rt, 2 h, 78%; d) 10 mol% (S,S)-8, benzaldehyde, 5, ZnMe2, toluene, 4 °C, 48 h, 88% (18:1 dr); e) H2 (1 atm), 5 mol% PtO2·H2O, EtOAc, RT, 1 h, 92%; f) TBAI, KHMDS, PMBCl, THF, rt, 90%; g) HF·pyr, pyr, THF, 50% + 20% diol; h) COCl2, DMSO, Et3N, CH2Cl2, 98%. DMPU = 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone, TBSCl = t-butyldimethylsilyl chloride, TBAI = tetrabutylammonium iodide, KHMDS = potassium bis(trimethylsilyl)amide, PMBCl = 4-methoxybenzyl chloride, pyr = pyridine.
The alkyne fragment was prepared starting from 4-heptyn-3-ol (11, Scheme 3). Oxidation followed by hydrosilylation afforded ketone 6. At this point, attempts at a chelation-controlled diastereoselective aldol between ketone 6 and aldehyde[16]7 was examined. Classical metal-enolate aldols using the enolate generated from LDA or by soft enolization techniques (TiCl4/NR3) were futile and led to decomposition of 6 along with recovery of 7. Turning to a Mukaiyama aldol process, deprotonation of 6 with LDA followed by trapping with TMSCl allowed for the synthesis of silyl enol ether 12 as a ~1:1 mixture of E- and Z-isomers. Since the diastereoselectivity of some Mukaiyama aldol reactions have been shown to be independent of silyl enol ether geometry, presumably due to the involvement of open transition states,[17] the mixture of enols (12) was subjected to these types of conditions. Gratifyingly, the use of TiCl4 as Lewis acid furnished the syn aldol adduct 13. Subsequent 1,3-syn reduction of enone 13,[18] followed by alcohol directed epoxidation of the vinyl silane, and protection of the 1,3-diol allowed for stereoselective synthesis of epoxysilane 14. Finally, the terminal alkyne was installed by hydrogenolysis of the primary benzyl ether, followed by Moffatt-Swern oxidation of the primary alcohol, and conversion to the alkyne using the Ohira-Bestmann reagent.[19]
Scheme 3.

Synthesis of the alkyne fragment. a) NaHCO3, 10 mol % KBr, 1 mol % TEMPO, NaOCl, RT, 1 h, 75%; b) 0.5 mol % [Cp*Ru(MeCN)3]PF6, benzyldimethylsilane, 0 °C to RT, 30 min, 86%; c) LDA, TMSCl, THF, −78 °C to RT, > 99%, ~1:1 E:Z; (d) aldehyde 7, TiCl4, CH2Cl2, −78 °C, 9:1 dr, 73% (yield of major diastereomer); e) Et2BOMe, NaBH4, THF/MeOH, −78 °C, 4 h; 30% H2O2, 84%, > 50:1 dr; f) m-CPBA, CH2Cl2, −25 °C, 36 h, 8:1 dr, 75% desired epimer; g) 2-methoxypropene, PPTS, CH2Cl2, RT, 1 h, 82%; h) H2 (1 atm) 10 wt% Pd/C, EtOAc, RT, 24 h, 91%; (i) (COCl)2, DMSO, CH2Cl2, Et3N; dimethyl-1-diazo-2-oxopropylphosphonate, NaOMe, THF, −78 °C to −40 °C, 81% over 2 steps. BDMS = benzyldimethylsilyl, Cp* = pentamethylcyclopentadienyl, TEMPO = 2,2,6,6-tetramethylpiperidin-1-yloxyl, LDA = lithium diisopropylamide, TMSCl = chlorotrimethylsilane, m-CPBA = m-chloroperbenzoic acid, PPTS = pyridinium toluene-para-sulfonate.
With aldehyde 10 and alkyne 15 in hand, conditions for joining the two fragments via a Felkin-controlled metal acetylide addition were explored (Scheme 4). Interestingly, use of the alkynyl titanate of 15 (not shown) gave the product of formal chelation-controlled addition in good diastereoselectivity (9:1 dr) despite the tendency of these reagents to give good Felkin-controlled addition.[20] Only the lithium acetylide of 15 was found to slightly favor the Felkin addition product (16). Various additives that are potential Li-atom chelators were examined with the hypothesis that this chelation may increase the steric bulk of the Li-acetylide and thereby increase the selectivity for the Felkin product. Ultimately, use of TMEDA as an additive led to the formation of 16 in 4.8:1 dr and excellent yield. However, the diastereomers could not be separated at this point, and the mixture was carried forward.
Scheme 4.

Completion of the synthesis. a) TMEDA, n-BuLi, THF, −78 °C to −20 °C, 92% (4.8:1 dr); b) Me3OBF4, proton sponge, CH2Cl2, RT, 1.5 h, 89%; c) UHP, TBAF (syringe-pump addition), THF, 0 °C to RT, 2 h, 75%; d) HF·pyr, pyr, THF, RT, 48 h, 92%; e) NH(SiMe2H)2 (neat), 85 °C, 3 h; f) 5 mol% CpRu(MeCN)3PF6, CH2Cl2, RT, 2 h; g) AgF, DMSO, MeOH, H2O, THF, RT, 1.5 h, 60% over 3 steps; h) Me3OBF4, proton sponge, CH2Cl2, RT, 2 h, 88%; i) LDA (4.0 equiv), THF, −78 °C; then Et2O, HMPA, methyl cyanoformate, 57–75%, 1:1 dr; j) 60% AcOH, 55 °C, 3 h, 68%; k) Mg(OMe)2, MeOH, RT, 12 h; 60% AcOH, 55 °C, 2 h, 53% after 3 cycles; l) amberlyst-15, MeOH, RT, 9 h, 70%; m) DDQ, pH 7 buffer, CH2Cl2, MeOH, 4 °C, 5 h, 80%; n) Ba(OH)2·8H2O, MeOH, 55 °C, 12 h, 75%; o) MNBA, DMAP, toluene, 4Å MS, syringe-pump addition of 23, 17 h, 25%; p) 1M HCl, THF, RT, 25 min, > 99%. TMEDA = N,N,N′,N′-tetramethylethylenediamine, UHP = urea hydrogen peroxide, TBAF = tetrabutylammonium fluoride, Cp = cyclopentadienyl, LDA = lithium diisopropylamide, HMPA = hexamethylphosphoramide, DDQ = 2,3-dichloro-5,6-dicyano-para-benzoquinone, MNBA = 2-methyl-6-nitrobenzoic anhydride, DMAP = 4-dimethylaminopyridine, MS = molecular sieves.
With access to 16, we turned our attention to Tamao-Fleming[21] oxidation of the epoxysilane moiety of 16 to unmask the α-hydroxyketone. First, the secondary alcohol was methylated with Meerwein’s salt, and Tamao-Fleming oxidation was then explored. The use of aqueous H2O2, under conditions first reported by Hosomi and coworkers[22] that we have previously exploited for this transformation,[11] led to substantial amounts of protodesilylation. However, under anhydrous conditions developed in our laboratory,[11] using urea hydrogen peroxide complex (UHP) as oxidant, clean oxidation was observed in good yield with only small amounts of protodesilylation (ca 10–15%). The secondary TBS ether was not deprotected during the oxidation, and subsequent deprotection was achieved using HF·pyr to afford 17.
Synthesis of the C9-C10 trans olefin by hydrosilylation/protodesilylation of the internal alkyne of 17 was next examined. Silylation of the secondary alcohols of 17, followed by hydrosilylation[9] afforded vinylsilane 19, which was subjected to protodesilylation without purification. A variety of protodesilylation conditions were examined; however, only AgF was successful in this system[23] allowing access to 20 in good overall yield from 17. It was at this point that the epimeric mixture at C11 could be separated by chromatography.
To complete the synthesis, formation of the hemiketal portion of 1 and macrolactonization was required. Global methylation of the free alcohols in 20, followed by Mander’s carboxylation of the enolate formed from kinetic deprotonation of the ketone provided 21 as an inseparable mixture of epimers at C2. Heating this mixture in aqueous acetic acid removed the acetonide protecting group and facilitated cyclization furnishing hemiketals 22a and 22b, which were separable by chromatography. Subjection of the incorrect epimer (22a) to basic conditions to allow access to the open form of 22a, followed by treatment with acid to reform the cyclic hemiketal allowed for epimerization of 22a to a ~1.4:1 mixture of 22a:22b in 75% yield. Separation and recycle of 22a allowed for the conversion of 22a to 22b in 53% overall yield after 3 cycles.
At this point all that remained to complete the synthesis of 1 was formation of the macrocycle. Seco-acid 23 was prepared by initial conversion of hemiketal 22b to the corresponding methyl ketal, followed by removal of the PMB protecting group, and lastly saponification of the methyl ester furnished the desired seco-acid 23. Previous studies by Höfle and coworkers[1c] had shown that a related analogue to 23 bearing a protecting group on the C5 hydroxyl was inert to typical macrolactonization procedures that rely on activation of the carboxylic acid functionality. However, Höfle was able to effect macrolactonization of this system through a four step sequence utilizing activation of the alcohol moiety. While our synthesis is amenable to this approach by protection of the C5 hydroxyl of 22b prior to PMB deprotection and saponification, this route is somewhat cumbersome. Furthermore, it was envisioned that the absence of a protecting group at the C5 hydroxyl might allow for more efficient macrolactonization. Therefore, we chose to examine the viability of directly converting 23 to the desired macrolactone using this approach. Gratifyingly, macrolactonization of 23 using Shiina’s method[24] furnished the desired macrolactone. Subsequent removal of the methyl ketal[1c] afforded synthetic 1 whose spectral data was consistent with the natural product.
In conclusion, we have prepared 1 in 25 linear and 34 total steps beginning from commercial materials 11, glycidol, and methyl (S)-3-hydroxy-2-methylpropiolate.[16] This synthesis further illustrates the versatility of the alkyne functional group in complex molecule synthesis.
Supplementary Material
Footnotes
We thank the National Institute of Health (GM13598) for their generous support of our program, and S. Lynch for assistance with NMR pectroscopy. JDS thanks the American Cancer Society for a post-doctoral fellowship. We gratefully thank Johnson and Matthey for donation of precious metal salts, and Aldrich Chemical Co. for donation of (S,S)-8.
Supporting information for this article is available on the WWW under http://www.angewandte.org or from the author.
References
- [1].a) Reichenback H, Höfle G, Augustiniak H, Bedorf N, Forche E, Gerth K, Irschik H, Jansen R, Kunze B, Sasse F, Steinmetz H, Trowitzsch-Kienast W, Pachlatko JP. EP 282455. 1988;A2 [Google Scholar]; b) Bedorf N, Schomburg D, Gerth K, Reichenbach H, Höfle G. Liebigs Ann. 1993:1017. [Google Scholar]; c) Schummer D, Jahn T, Höfle G. Liebigs Ann. 1995:803. [Google Scholar]
- [2].Gerth K, Bedorf N, Irschik H, Höfle G, Reichenbach H. J Antibiot. 1994;47:23. doi: 10.7164/antibiotics.47.23. [DOI] [PubMed] [Google Scholar]
- [3].Vahlensieck HF, Pridzun L, Reichenbach H, Hinnen A. Curr Genet. 1994;25:95. doi: 10.1007/BF00309532. [DOI] [PubMed] [Google Scholar]
- [4].Weatherly SC, Volrath SL, Elich TD. Biochem J. 2004;380:105. doi: 10.1042/BJ20031960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K, Verhoeven G, Swinnen JV. Cancer Res. 2007;67:8180. doi: 10.1158/0008-5472.CAN-07-0389. [DOI] [PubMed] [Google Scholar]
- [6].a) Abel S, Faber D, Hüter O, Giese B. Angew Chem Int Ed. 1994;33:2466. [Google Scholar]; Angew Chem. 1994;106:2522. [Google Scholar]; b) Abel S, Faber D, Hüter O, Giese B. Synthesis. 1999:188. [Google Scholar]
- [7].a) Díaz-Oltra S, Murga J, Falomir E, Carda M, Peris G, Marco JA. J Org Chem. 2005;70:8130. doi: 10.1021/jo051307p. [DOI] [PubMed] [Google Scholar]; b) Park SH, Lee HW, Park S-U. Bull Korean Chem Soc. 2004;25:1613. [Google Scholar]; c) Lee HW, Lee I-YC, Kim Y-S, Park S-U. Bull Korean Chem Soc. 200223:1197. [Google Scholar]; d) Gurjar MK, Mainkar AS, Srinivas P. Tetrahedron Lett. 1995;36:5967. [Google Scholar]; e) Loubinoux B, Sinnes J-L, O’Sullivan AC, Winkler T. Helv Chim Acta. 1995;78:122. [Google Scholar]; f) Loubinoux B, Sinnes J-L, O’Sullivan AC, Winkler T. J Org Chem. 1995;60:953. [Google Scholar]; g) Cao Y, Eweas AF, Donaldson WA. Tetrahedron Lett. 2002;43:7831. [Google Scholar]; h) Lee HW, Kim YJ. Bull Korean Chem Soc. 1996;17:1107. [Google Scholar]; i) Vincent G, Mansfield DJ, Vors J-P, Ciufolini MA. Org Lett. 2006;8:2791. doi: 10.1021/ol060882s. [DOI] [PubMed] [Google Scholar]; j) Park SH, Lee HW. Bull Korean Chem Soc. 2008;29:1445. [Google Scholar]; k) Eweas AH. Synth Commun. 2008;38:1541. [Google Scholar]
- [8].Stang PJ, Diederich F, editors. Modern Acetylene Chemistry. WILEY-VCH; Weinheim: 1995. [Google Scholar]
- [9].a) Trost BM, Ball ZT, Jöge T. J Am Chem Soc. 2002;124:7922. doi: 10.1021/ja026457l. [DOI] [PubMed] [Google Scholar]; b) Trost BM, Ball ZT. J Am Chem Soc. 2005;127:17644. doi: 10.1021/ja0528580. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Trost BM, Ball ZT. J Am Chem Soc. 2003;125:30. doi: 10.1021/ja028766h. [DOI] [PubMed] [Google Scholar]
- [10].Review:; Parenty A, Moreau X, Campagne J-M. Chem Rev. 2006;106:911. doi: 10.1021/cr0301402. [DOI] [PubMed] [Google Scholar]
- [11].Trost BM, Ball ZT, Laemmerhold KM. J Am Chem Soc. 2005;127:10028. doi: 10.1021/ja051578h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Trost BM, Weiss AH, Jacobi von Wangelin A. J Am Chem Soc. 2006;128:8. doi: 10.1021/ja054871q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].a) Brown CA, Yamashita A. J Am Chem Soc. 1975;97:891. [Google Scholar]; b) Macaulay SR. J Org Chem. 1980;45:734. [Google Scholar]; c) Abrams SR, Shaw AC. Organic Syntheses. 1988;66:127. [Google Scholar]
- [14].Voorhees V, Adams R. J Am Chem Soc. 1922;44:1397. [Google Scholar]
- [15].Entwistle ID, Wood WD. In: Comprehensive Organic Synthesis. Fleming I, Trost BM, editors. Vol. 8. Pergamon Press; New York: 1991. pp. 955–981. [Google Scholar]
- [16].Aldehyde 7 was prepared from methyl (S)-(+)-3-hydroxy-2-methylpropiolate in 67% overall yield, see supporting information.
- [17].a) Gennari C, Beretta MG, Bernardi A, Moro G, Scolastico C, Todeschini R. Tetrahedron. 1986;42:893. [Google Scholar]; b) Heathcock CH, Davidsen SK, Hug KT, Flippin LA. J Org Chem. 1986;51:3027. [Google Scholar]
- [18].a) Chen K-M, Hardtmann GE, Prasad K, Repiĉ O, Shapiro MJ. Tetrahedron Lett. 1987;28:155. [Google Scholar]; b) Hoveyda AH, Evans DA, Fu GC. Chem Rev. 1993;93:1307. [Google Scholar]; c) Tempkin O, Abel S, Chen C-P, Underwood R, Prasad K, Chen K-M, Repic O, Blacklock TJ. Tetrahedron. 1997;53:10659. [Google Scholar]
- [19].Muller S, Liepold B, Roth GJ, Bestmann HJ. Synlett. 1996:521. [Google Scholar]
- [20].Guillarme S, Plé K, Banchet A, Liard A, Haudrechy A. Chem Rev. 2006;106:2355. doi: 10.1021/cr0509915. [DOI] [PubMed] [Google Scholar]
- [21].a) Tamao K, Akita M, Kumada M. J Organomet Chem. 1983;254:13. [Google Scholar]; b) Tamao K, Kumada M, Maeda K. Tetrahedron Lett. 1984;25:321. [Google Scholar]; c) Fleming I, Henning R, Parker DC, Plaut HE, Sanderson PEJ. J Chem Soc, Perkin Trans 1. 1995:317. [Google Scholar]; d) Review: Jones GR, Landais Y. Tetrahedron. 1996;52:7599. [Google Scholar]
- [22].a) Miura K, Hondo T, Takahashi T, Hosomi A. Tetrahedron Lett. 2000;41:2129. [Google Scholar]; b) Miura K, Hondo T, Nakagawa T, Takahasi T, Hosomi A. Org Lett. 2000;2:385. doi: 10.1021/ol991341o. [DOI] [PubMed] [Google Scholar]
- [23].Fürstner A, Radkowski K. Chem Commun. 2002:2182. doi: 10.1039/b207169j. [DOI] [PubMed] [Google Scholar]
- [24].Shiina I, Kubota M, Oshiumi H, Hashizume M. J Org Chem. 2004;69:1822. doi: 10.1021/jo030367x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
